跳至主要内容
临床试验/IRCT2016022225507N2
IRCT2016022225507N2已完成2 期

Effectiveness of pregabalin as an adjuvant therapy for chronic nonbacterial prostatitis

Vice Chancellor for Research of Arak University of Medical Sciences0 个研究点目标入组 288 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
288

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 139 years(—)
性别
Male

入选标准

  • 1) Age over 18 years; 2) no prior history of other urinary system disorders such as urinary tract stones, neurogenic bladder, and urinary infections; 3) no history of major underlying diseases such as cirrhosis, renal failure, diabetes, or hypertension; 4) normal levels of urine, fasting blood sugar (FBS), and creatinine; 5) normal results on the first neurological examination of the perineal area, lower limbs, lower limb reflexes, and bulbocavernosus reflex; 6) no use of other medicines; 7) no signs of psychological disorders; 8) confirmed diagnosis of chronic prostatitis; 9) non-sensitivity to anti-epileptic drugs, pregabalin, thiazolidinediones, or other anti-diabetic agents.
  • Exclusion criteria: 1) Unwillingness to continue the study, and 2) major side-effects due to the use of medications.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Arak University of Medical Sciences

相似试验

Effectiveness of pregabalin on chronic nonbacterial... | 临床试验